https://www.fredhutch.org/en/news/center-news/rss2015-09-04T19:52:39.450ZCenter News RSS FeedAdobe Experience ManagerGood News at Fred HutchFred Hutch Visitor Center opens; Sage Bionetworks and Drs. Soheil Meshinchi and Heather Schuback receive St. Baldrick's grantshttps://www.fredhutch.org/en/news/center-news/2015/09/good-news-visitor-center-sage-meshinchi-schuback2015-09-03T18:50:48.000Z2015-09-03T18:50:48.000ZA little known side effect with a huge impactLymphedema has been called cancer’s “dirty little secret” since patients often don’t know they’re at risk for it, physicians may not recognize it and the condition can happen months or years after treatment. Compression garments vastly improve patients’ quality of life but Medicare and other insurers often don’t cover them.https://www.fredhutch.org/en/news/center-news/2015/09/lymphedema-cancer-treatment-side-effect2015-09-03T17:27:46.000Z2015-09-03T17:27:46.000ZFinding a better (mis)matchSoon, many patients coming to Seattle for blood stem cell transplants will have a lower risk of a potentially life-threatening complication thanks to additional genetic testing, which will be built on findings published this month by a team of Fred Hutch researchers led by Dr. Effie Wang Petersdorf.https://www.fredhutch.org/en/news/center-news/2015/08/transplant-matching-method-for-reducing-GVHD2015-08-28T15:00:00.000Z2015-08-28T15:00:00.000Z ‘A reminder of this journey’: One gift linking three lives Jessica Mann holds the mouse figurine that her late mother, then a leukemia patient at Fred Hutch, gifted to an SCCA nurse more than 20 years ago.https://www.fredhutch.org/en/news/center-news/2015/08/mouse-replica-inspires-oncology-nurse-gives-daughter-hope2015-08-27T21:46:21.000Z2015-08-27T21:46:21.000ZGood News at Fred HutchDr. Roland Walter receives two grant awards for acute leukemia research; Dr. Jonathan Bricker to keynote behavioral therapy conference; Dr. Benjamin Anderson chairs NCCN committee that publishes clinical-practice guidelines for cervical cancerhttps://www.fredhutch.org/en/news/center-news/2015/08/good-news-walter-bricker-anderson2015-08-27T19:42:08.000Z2015-08-27T19:42:08.000Z'A chance to hope’: Leukemia survivor, family reunite with favorite doctorAfter her husband, Hugh, was diagnosed with an aggressive form of leukemia, Aimee Fagan filled a notebook with doctors' names, study results, and this mantra: 'It's you and me against cancer, do you think it has a chance?'https://www.fredhutch.org/en/news/center-news/2015/08/leukemia-survivor-reunites-with-cord-blood-transplant-researcher2015-08-27T04:45:25.000Z2015-08-27T04:45:25.000ZStress-lowering heart drug may boost ovarian cancer survivalWomen with ovarian cancer who took a certain type of beta-blocker for heart problems unrelated to their cancer lived more than four years on average longer than those who did not take the drug, a study finds. https://www.fredhutch.org/en/news/center-news/2015/08/study-underscores-stress-ovarian-cancer-suggests-beta-blocker-may-help2015-08-25T23:09:16.000Z2015-08-25T23:09:16.000ZThe microbiome’s murky role in pregnancy loss and complicationA study published recently by scientists at Temple University and Fred Hutchinson Cancer Research Center found that the very same bacteria can have entirely different effects on women’s risk of premature delivery or miscarriage. And that dichotomy — one bacteria causing help and harm — has researchers both baffled and intrigued. https://www.fredhutch.org/en/news/center-news/2015/08/microbiome-role-pregnancy-loss-complication2015-08-21T22:34:40.000Z2015-08-21T22:34:40.000ZHow cells put themselves to sleepBiologists, by definition, study life. But a group of molecular biologists at Fred Hutchinson Cancer Research Center have spent the past several years studying a physiological state that’s pretty much as un-lifelike as living systems get, a condition known as cellular quiescence.https://www.fredhutch.org/en/news/center-news/2015/08/how-cells-put-themselves-to-sleep2015-08-20T16:00:00.000Z2015-08-20T16:00:00.000ZAn easy pairingFred Hutch’s Harlan Robins has developed a new method to quickly and easily match thousands of pairs of key genes needed for cancer immunotherapyhttps://www.fredhutch.org/en/news/center-news/2015/08/pairseq-fast-tracks-immunotherapy2015-08-19T22:18:41.000Z2015-08-19T22:18:41.000ZFantastic failures: Scientific setbacks fuel big gainsThe dirty dance of a fruitful lab investigation often goes this way: One step back, two steps forward. Numerous scientific leaps, in fact, looked for a time like basic blunders or even full flops - from Einstein to Pauling. https://www.fredhutch.org/en/news/center-news/2015/08/scientific-failures-can-fuel-historic-progress2015-08-18T21:34:12.000Z2015-08-18T21:34:12.000ZA box to open horizonsCristina McAllister, a research technician at Fred Hutch, is developing appealing, approachable science experiments-of-the-month that will be mailed to girls aged 7 to 14 who subscribe to the service, called StemBox. https://www.fredhutch.org/en/news/center-news/2015/08/stembox-science-kits-open-horizons2015-08-17T16:00:00.000Z2015-08-17T16:00:00.000ZHIV cure research today: Gene therapy, molecular scissors and Where’s WaldoFrom across the country, HIV experts and cancer researchers who have devoted their careers to improving stem cell transplants came together at Fred Hutchinson Cancer Research Center Thursday and Friday. Their goal? To talk about how to translate the world’s only known person to be cured of HIV to a cure or long-term remission that is less risky, less costly and broadly applicable to the millions worldwide now living with the virus.https://www.fredhutch.org/en/news/center-news/2015/08/hiv-cure-research-today2015-08-14T23:35:13.000Z2015-08-14T23:35:13.000Z‘Turn it into something good’For 19-year-old Margo Coxon, a summer internship at Fred Hutch wasn’t just something to add to her resume -- it was a chance to help find a cure for the disease that took her sister’s life. https://www.fredhutch.org/en/news/center-news/2015/08/margo-coxon-intern-olson-lab2015-08-14T22:24:51.000Z2015-08-14T22:24:51.000ZGood News at Fred HutchDr. Amanda Paulovich wins proteomic sciences award; Dr. David Coffey receives ASH research training award; endowed chair named in honor of the late Dr. Stephen Petersdorfhttps://www.fredhutch.org/en/news/center-news/2015/08/good-news-paulovich-coffey-petersdorf2015-08-13T18:28:10.000Z2015-08-13T18:28:10.000ZHIV cure: From pipe dream to promisingCuring HIV – which less than a decade ago was considered so unlikely it was not even a serious candidate for research – is now the focus of a conference drawing community advocates, students and many of the nation’s leading scientists working on HIV. Nobel Laureate Dr. David Baltimore, who has made major contributions to both HIV and cancer research and is now working to develop gene therapy cures for both, will deliver the keynote talk this morning.https://www.fredhutch.org/en/news/center-news/2015/08/hiv-cure-conference-cautious-optimism2015-08-13T15:33:47.000Z2015-08-13T15:33:47.000ZMore than 1,000 Obliteride riders rally to support Fred HutchBy ones and twos and threes and fives, more than a thousand Obliteride riders rolled into Seattle’s Gas Works Park on Sunday, marking the end of a triumphant weekend of bicycle-borne determination to fight back against cancer.https://www.fredhutch.org/en/news/center-news/2015/08/obliteride-riders-rally-for-fred-hutch2015-08-10T18:05:53.000Z2015-08-10T18:05:53.000ZThird-annual Obliteride weekend is hereThe countdown is over. Obliteride is here. After a glorious kick-off party that lit up Seattle’s Gas Works Park on Friday evening, the first contingent of 125 hard-core bicyclists hit the road at 7 a.m. on Saturday on their first leg of a two-day, 150-mile trek to raise money for Fred Hutchinson Cancer Research Center.https://www.fredhutch.org/en/news/center-news/2015/08/third-annual-obliteride-is-here2015-08-09T17:50:00.000Z2015-08-09T17:50:00.000ZGood News at Fred HutchMore than two dozen Hutch researchers to present next week at largest statistical conference in North America
The largest gathering of statisticians in North America will convene next week in Seattle.
The Joint Statistical Meeting (JSM2015), set for Aug. 8-13 at the Washington State Convention Center, will feature academic, government and industry statisticians from the American Statistical Association, International Biometric Society, Institute of Mathematical Statistics, Royal Statistical Society, International Statistical Institute and other organizations. Some 5,000 statisticians are expected to attend.
More than two dozen researchers from Fred Hutch’s Public Health Sciences and Vaccine and Infectious Disease divisions will present work and/or lead discussions, including PHS Division Director Emeritus Dr. Ross Prentice, who will speaking on “Challenges in the Identification and Validation of Surrogate Markers,”
"It is one of the few professional society meetings in which I have been an attendee, and usually a speaker, for almost every year since 1970," he said. "It's a place to make connections ... and engage in updates on a broad range of quantitative topics in study design, conduct and analysis of research studies."
Other speakers from the Hutch will include Dr. Charles Kooperberg, presenting on “Quantification of Multiple Tumor Clones Using Gene Array Data,” Dr. Li Hsu, speaking on “Shedding Light on the Biology of Complex Diseases Using Cutting-Edge Statistical Methods for Family Data,” Dr. Holly Janes, presenting on “The Challenge in Making Inference About a Biomarker's Predictive Capacity,” and Dr. Ruth Etzioni, presenting on “Limitations of Screening Trials in Developing Cancer Screening Policies.”
Other Hutch researchers participating in JSM2015 include Drs. Sean Wang, Michael Wu, Michael LeBlanc, Ying Qing Chen, Sahar Zangenah, Ying Huang, Yu-Ru Su, Masanao Yajima, Chad He, Charles Cheung, Takumi Saegusa, Peter Gilbert, Su-Ching Chang, Frederick Matsen, Jean deDieu, SoYoung Kim, Ni Zhao, Frederick Matsen, Catherine Tangen, Yanqing Wang and Yichen Cheng.
Co-sponsored by Fred Hutch (among many other institutions and organizations), the JSM will offer five days of keynote speakers, panel discussions, round-table discussions, invited paper presentations and poster presentations along with many opportunities for professional development, recruitment and socializing. https://www.fredhutch.org/en/news/center-news/2015/08/good-news-nelson-prentice2015-08-06T22:53:36.000Z2015-08-06T22:53:36.000Z7 questions for Nobel Laureate David BaltimoreNobel Laureate Dr. David Baltimore will be the keynote speaker at the 2015 Conference on Cell and Gene Therapy for HIV Cure held Aug. 13-14 at Fred Hutch. He will also take part in a community conversation about gene therapy for HIV/AIDS on the eve of the conference that is free and open to the public. To speak at an HIV cure conference held at a cancer research center is especially appropriate because Baltimore’s work in immunology and virology has profoundly influenced both HIV and cancer research, said Dr. Hans-Peter Kiem.https://www.fredhutch.org/en/news/center-news/2015/08/questions-for-nobel-laureate-david-baltimore2015-08-06T18:46:31.000Z2015-08-06T18:46:31.000Z